By Sandy Garcon, Communications Manager, PSI UNITAID’s executive director discusses the importance of developing and unlocking markets to accelerate innovations in growth. 1. Impact: Why are markets systems important to the poor? LM: The poorest people are typically the most vulnerable in society, and often the most directly affected by changing or underdeveloped market conditionsRead More ›
By Sabrina Sidhu, Writer, UNITAID Malicious gossip can spread faster than wildfire. Traditional leaders in rural Neno District, Malawi, are only too aware of its destructive nature. In May this year, they grew worried that rumours could jeopardize HIV self-testing, a new health service that relies on strict confidentiality for its success. HIV self-testing allowsRead More ›
By Karin Hatzold, Project Director, PSI/UNITAID/HIV Self Test AfRica Almost universally, men interact with health systems far less than women. In sub-Saharan Africa and in countries with high HIV burden, the consequences are real: men are less likely to know their HIV status; are diagnosed later in the course of infection and less likely toRead More ›
Last week, PSI Global Ambassador and actress Debra Messing visited Washington, DC, to lend her voice to the growing call to end the AIDS epidemic and help fund programs that address the increased risk of HIV infections in women and girls in developing countries. Ms. Messing first spoke at the State Department on Monday. SheRead More ›
By Margaret Cohen, Online Engagement and Fundraising, PSI “I just wanted to share a little story about someone I met who had AIDS,” begins Teri, a former medical technician remembering the day in 1982 the first AIDS patient walked through the doors of her suburban Minneapolis hospital. She is warmed by the gratitude heRead More ›
By Jenny Tolep and Etiti Ayeni, External Relations and Communications There is no question that this summer has been jam-packed with shark scares. From professional surfer, Mick Fanning’s close encounter to the numerous shark bites in North Carolina’s unusually warm waters, it is not surprising that people are nervous about getting in the ocean. SharksRead More ›
By Anna Dirksen, PSI Consultant Earlier this month, The Diplomat — one of the leading international news outlets for Asia-Pacific — published an article on a community-based HIV testing program in Cambodia, calling it “the first of its kind in the region”. The article describes the incredible battle Cambodians are waging against HIV, with anRead More ›
As world leaders met in Addis Ababa to discuss financing for the Sustainable Development Goals, the Global Fund announced mid-year results that demonstrate strong progress against HIV, tuberculosis and malaria. The results show that 8.1 million people are receiving antiretroviral treatment for HIV through programs supported by Global Fund grants, a 22% increase since theRead More ›
Nina Hasen recently joined PSI as the Director of HIV and Tuberculosis. Coming to us from the Office of the Global AIDS Coordinator (OGAC), which oversees the President’s Emergency Response for AIDS Relief (PEPFAR), Nina brings not only expertise in HIV and AIDS programming and policy, but also a strong scientific and academic background throughRead More ›
By Anna Dirksen, PSI Consultant America was buzzing this week with talk about the 22-page Vanity Fair spread on Caitlyn Jenner that dropped onto newsstands June 9th. Caitlyn, who first became famous winning the gold medal in the men’s decathlon event at the 1976 Summer Olympics, talks openly in the article about how difficult it was for her to comeRead More ›
Q&A with Duncan Blair, Director of Public Health Initiatives, Alere, Inc.
Impact: How do you define innovation? What do you think are some of the most important factors driving innovation in global health?
Read More ›
DB: Innovation is not only about delivering something new but also about delivering something which provides positive outcomes. What you need for innovation really is creative and engaged people — it’s all about people being willing to challenge the status quo. If everybody always thinks the same things, talks the same language and simply tows the party line then that’s not an environment very conducive to innovation. So what you need is people and an environment that fosters and encourages group members to take risks, whether this is an R&D team, a marketing team, a program implementation team, or a policy development team. Without people who are willing to state their opinion and argue their position then you have no innovation.
More sustained financing is needed to continue global progress against HIV/AIDS. Given the current challenges to global health financing, new solutions are vital to changing the current rate of progress.
“There is a moral obligation to maintain treatment for those who need it, and considerable resources have been implicitly pre-committed to lifelong HIV treatment and care,” say the authors of a recent paper published in the PLoS Medicine journal.
More money also needs to be better spent, they argue. HIV work must be linked to health systems strengthening, a move that will both increase the reach of HIV work and support the underlying health problems that contribute to the problem.
Financing the HIV response must also be achieved without damaging investments in health systems more broadly and other development sectors that are essential for social welfare (in turn addressing a number of the barriers to scaling up the HIV response). An HIV programme may have important external benefits for sexual and reproductive health; maternal and child health; or provide the necessary health system platforms for managing chronic conditions. Similarly, investments in strengthening health systems or addressing related co-morbidities that compound HIV vulnerability or worsen treatment outcomes are critically important to individuals living with HIV. Although core HIV interventions have been demonstrated to be cost-effective, total HIV spending in sub-Saharan African countries was an estimated 19.4% of total health spending in 2007 (range: 0.7%–64.4%). This amount exceeds the relative burden of HIV disability-adjusted life years and is at least partly due to the relatively high costs of HIV treatment compared to treatment for other prevalent diseases. There remains a difference between the amount spent on the HIV response across countries with a similar GDP per capita and HIV prevalence, and more work is required to understand the optimal level of domestic resourcing for HIV, given competing health sector priorities.
There are examples of innovative financing schemes, but they face challenges. The authors recognize that overtaxing and a hyper-focus on HIV/AIDS can do more harm than good. A careful approach that applies lessons learned can ensure changes are effective.
Innovative revenue streams are currently being explored in several countries. These schemes can generate significant funds, as seen in Zimbabwe with the 3% AIDS levy deducted from businesses and formal sector workers’ salaries since 2000 . Other options, such as increased “sin taxes” on alcohol, could generate a “double dividend” by simultaneously increasing revenues and decreasing HIV-related risk behaviours . The development of social health insurance could help attract further household resources and may be an important new source of financing in middle-income countries as development assistance scales down
Read the full research paper here.Read More ›